Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:18 PM
Ignite Modification Date:
2026-03-26 @ 3:18 PM
NCT ID:
NCT07373067
Eligibility Criteria:
Inclusion Criteria:
1. Successful completion of the Phase 1 single dose administration study of RB-ADSC, Protocol RB-ADSC-02.
2. Written informed consent to participate in this Phase 1b Extension Study either provided by the participant or a legal representative
3. The participant must have a relative/caregiver who is alert for possible side effects.
4. The caregiver must separately meet the specified inclusion/exclusion criteria for caregivers for this Phase 1b Extension Study.
Exclusion Criteria:
1. Participant experienced treatment related SAE or DLT in Protocol RB-ADSC-02
2. Participants who, in the opinion of the Investigator, are unsuitable for this Phase 1 Extension Study
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
45 Years
Study:
NCT07373067
Study Brief:
Protocol Section:
NCT07373067